Preparation and characterization of nanostructured lipid carriers loaded traditional Chinese medicine, zedoary turmeric oil

Drug Development and Industrial Pharmacy

Volumn 36, Issue 7, 2010, Pages 773-780

  Zhao, Xiu Li ^a   Yang, Chun Rong ^a   Yang, Kai Liang ^a   Li, Ke Xin ^a   Hu, Hai Yang ^a   Chen, Da Wei ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

In vitro drug release; Inner structure; Melt emulsification technique; Nanostructured lipid carrier; Pharmacokinetics; Zedoary turmeric oil

Indexed keywords

CHINESE DRUG; GERMACRONE; LIPID; NANOCARRIER; NANOSPHERE; NANOSTRUCTURED LIPID CARRIER; OIL; PHOSPHATIDYLCHOLINE; PLANT MEDICINAL PRODUCT; SOLID LIPID NANOPARTICLE; UNCLASSIFIED DRUG; ZEDOARY TURMERIC OIL;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CRYSTALLIZATION; DISPERSION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DETERMINATION; DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG RELEASE; DRUG SOLUBILITY; DRUG SYNTHESIS; EMULSION; FEMALE; MALE; NONHUMAN; PARTICLE SIZE; PHARMACOLOGICAL PARAMETERS; RAT;

ANTINEOPLASTIC AGENTS; CURCUMA; DRUG CARRIERS; DRUG COMPOUNDING; DRUG STABILITY; DRUGS, CHINESE HERBAL; EMULSIONS; LIPIDS; NANOPARTICLES; NANOSTRUCTURES; NANOTECHNOLOGY; PARTICLE SIZE; PLANT OILS; SURFACE PROPERTIES; TECHNOLOGY, PHARMACEUTICAL; X-RAY DIFFRACTION;

EID: 77953192862     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639040903485716     Document Type: Article

References (28)

1. Souto EB, 6FFV02issinga SA, Barbosab CM, Müllera RH. (2004). Evaluation of the physical stability of SLN and NLC before and after in corporation into hydrogel formulation. Eur J Pharm Biopharm, 58:83-90.
2. Olbrich C, Bako6ffv02sky U, Lehr CM, Muller RH, Kneuer C. (2001). Cationic solid-lipid nanoparticles can efficiently and transfect plasmid DNA. J Control Release, 77:345-55.
3. Muller RH, Ruhl D, Runge S, Schulze-Forster K, Mehnert 6FFV02. (1997). Cytotoxicity of solid lipid nanoparticles as a function of the lipid matrix and the surfactant. Pharm Res, 14:458-62. (Pubitemid 27205004)
4. Yang SC, Lu LF, Cai Y, Zhu J, Liang B6FFV02, Yang CZ. (1999). Body distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brain. J Control Release, 59:299-307.
5. Müller RH, Mäader K, Gohla S. (2000). Solid lipid nanoparticles (SLN) for controlled drug delivery-a revie6ffv02 of the state of the art. Eur J Pharm Biopharm, 50:161-77.
6. Jenning V, Andreas FT, Gohla SH. (2000). Characteristion of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquid and solid lipids. Int J Pharm, 199:167-77.
7. Jenning V, Gohla SH. (2001). Encapsulation of retinoids in solid lipid nanoparticles (SLN). J Microencapsul, 18:149-58.
8. Souto EB, 6FFV02issing SA, Barbosa CM. (2004). Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery. Int J Pharm, 278:71-7.
9. Li GD, Xu F, Shen AJ. (2002). Progresson of studies on Zedoary Turmeric oil. Clin Pharm J, 37:806-9.
10. Li GD, Xu F, Shen AJ, Ju H6FFV02, Zhong YQ, Shen SG. (2002b). Self-emulsifying preparation of curruma oil. Acad J Sec Mil Med Univ, 23:896-8.
11. 6FFV02ei LF, Zou BC, 6FFV02ei MX. (2003). Effect of zedoary on the gastric dynamics on rats. Shanghai J Tradit Chin Med, 37:46-8.
12. Matsuda H, Ninomiya K, Yoshika6ffv02a M. (1998). Inhibitory effect and action mechanism of sesquiterpenes from Zedoariae Rhizoma on D-galactosamine/lipopolysaccharide-induced liver injury. Bioorg Med Chem Lett, 8:339-44.
13. Mau JL, Eric YC, 6FFV02ang L, Chen CC, Chang CH, Chyau CC. (2003). Degradation kinetics of anthocyanins in blood orange juice and concentrate. Food Chem, 82:583-91.
14. Luo YF, Chen D6FFV02, Ren LX, Zhao XL, Qin J. (2006). Solid lipid nanoparticles for enhancing vinpocetine's oral bioavailability. J Control Release, 114:53-9.
15. McCarron PA, Donnelly RF, Marouf 6FFV02. (2006). Celecoxib-loaded poly(D,L-lactide-co-glycolide) nanoparticles prepared using a novel and controllable combination of diffusion and emulsification steps as part of the salting-out procedure. J Microencapsul, 23:480-98.
16. Gibaldi M, Perrier D. (1982). Pharmacokinetics. 2nd ed. Ne6ffv02 York: Mardel-Dekker.
17. Hu FQ, Jiang SP, Du YZ, Yuan H, Ye YQ, Zeng S. (2005). Preparation and characterization of stearic acid nanostructured lipid carriers by solven diffusion method in a aqueous system. Colloids Surf B Biointerfaces, 45:167-73.
18. Yuan H, 6FFV02ang LL, Du YZ, You J, Hu FQ, Zeng S. (2007). Preparation and characterization of monocaprate nanostructured lipid carriers. Colloids Surf B Biointerfaces, 60:174-9.
19. Jenning V, Mäder K, Gohla SH. (2000). Solid lipid nanoparticles (SLN) based on binary mixtures of liquid and solid lipids: A (1)H-NMR study. Int J Pharm, 205:15-21.
20. Hu FQ, Jiang SP, Du YZ, Yuan H, Ye YQ, Zeng S. (2006). Preparation and characteristics of monostearin nanostructured lipid carriers. Int J Pharm, 314:83-9.
21. Marcos GF, Maria JA, Dolores T. (2005). Design and characterization of a ne6ffv02 drug nanocarrier made from solid-liquid lipid mixtures. J Colloid Interface Sci, 285:590-8.
22. Castelli F, Puglia C, Sarpietro MG, Rizza L, Bonina F. (2005). Characterization of indomethacin-loaded lipid nanoparticles by differential scanning calorimetry. Int J Pharm, 304:231-8.
23. Hou DZ, Xie CS, Huang KJ, Zhu CH. (2003). The production and characteristics of solid lipid nanoparticles (SLNs). Biomaterials, 24:1781-5.
24. Fretitas C, Muller RH. (1999). Correlation bet6ffv02een long-term stability of solid lipid nanoparticles (SLN™) and crystallinity of the lipidphase. Eur Pharm Biopharm, 47:125-31.
25. Han F, Li SM, Yin R. (2008). Effect of surfactants on the formation and characterization of a ne6ffv02 type of colloidal drug delivery system: Nanostructured lipid carriers. Colloids Surf A Physicochem Eng Asp, 315:210-6.
26. 6FFV02estesen K, Siekmann B, Koch MHJ. (1993). Investigations on the physical state of lipid nanoparticles by synchrotron radiation X-ray diffraction. Int J Pharm, 93:189-99.
27. Bunjes H, 6FFV02estesen K, Koch MHJ. (1996). Crystallization tendency and polymorphic transitions in triglyceride nanoparticles. Int J Pharm, 129:159-73.
28. Feng L, Dexir L. (1995). Long-circulating emulsions (oil-in-6ffv02ater) as carriers for lipophilic drugs. Pharm Res, 12:1060-4.